Evidence map›Paper›PMID 33781296›Full record

ArticleJournal of nanobiotechnology2021

BiVO

Ze Wang, Guan Wang, Tingting Kang, Shuwei Liu, Lu Wang, Haoyang Zou, Yu Chong, Yi Liu

Open access · goldAbstract read
In one paragraph

Article in Journal of nanobiotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Assessment of CuFeSeNano convergence · 2025
    Article
  7. Review
  8. Article
  9. Flame spray pyrolyzed carbon-encapsulated Au/FeFrontiers in bioengineering and biotechnology · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Tween-20-Modified BiVOACS omega · 2023
    Article
  14. Article
  15. New anti-cancer explorations based on metal ions.Journal of nanobiotechnology · 2022
    Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ze Wang *State Key Laboratory of Supramolecular Structure and Materials, Jilin University, Changchun, 130012, People's Republic of China.
Guan Wang *Department of Gastroenterology, China-Japan Union Hospital, Jilin University, Changchun, 130033, People's Republic of China.
Tingting Kang *State Key Laboratory of Supramolecular Structure and Materials, Jilin University, Changchun, 130012, People's Republic of China.
Shuwei LiuState Key Laboratory of Supramolecular Structure and Materials, Jilin University, Changchun, 130012, People's Republic of China.
Lu WangDepartment of Oral Pathology, School and Hospital of Stomatology, Jilin University, Changchun, 130021, People's Republic of China.
Haoyang ZouKey Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130012, People's Republic of China. zzhhyy2004@126.com.
Yu ChongState Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Soochow University, Suzhou, 215123, People's Republic of China. chongyu@suda.edu.cn.
Yi LiuState Key Laboratory of Supramolecular Structure and Materials, Jilin University, Changchun, 130012, People's Republic of China. yiliuchem@jlu.edu.cn.ORCID http://orcid.org/0000-0003-0548-6073
Jilin University · CNChinese Academy of Sciences · CNSoochow University · CN

Funding

National Natural Science Foundation of China 21875086National Natural Science Foundation of China 21906110Natural Science Foundation of Jiangsu Province BK20170353Program for Jilin University Science and Technology Innovative Research Team 2017TD-06
6 · The paper itself

Abstract

backgroundDespite tremendous progress has been achieved in tumor theranostic over the past decade, accurate identification and complete eradication of tumor cells remain a great challenge owing to the limitation of single imaging modality and therapeutic strategy.

resultsHerein, we successfully design and construct BiVO

conclusionsSince there are many kinds of building blocks with unique properties appropriating for self-assembly, our work may largely enrich the library of nanomateirals for tumor diagnosis and treatment.

Indexed as

NanoparticlesAnimalsBismuthContrast MediaFerric CompoundsHumansIndolesMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMultimodal ImagingPhototherapyPolymersTomography, X-Ray ComputedVanadatesBismuthbismuth vanadium tetraoxideContrast MediaFerric Compoundsferric oxideIndolespolydopaminePolymersVanadatesBiVO4 nanoparticlesFe3O4 nanoparticlesMultimodal imagingSuperparticlesSynergy therapy

Identifiers

PMID33781296
PMCPMC8008624
OpenAlexW3129110369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.